Christian Borgo

Via U. Bassi 58/B
Padova, 35131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Regulation of the cell secretome by protein kinase CK2 modulates cell migration and extracellular matrix composition.

Regulation of the cell secretome by protein kinase CK2 modulates cell migration and extracellular matrix composition.

Journal: International journal of biological macromolecules

Published: May 20, 2025

Critical role of protein kinase CK2 in chronic myeloid leukemia cells harboring the T315I BCR::ABL1 mutation.

Critical role of protein kinase CK2 in chronic myeloid leukemia cells harboring the T315I BCR::ABL1 mutation.

Journal: International journal of biological macromolecules

Published: July 26, 2024

Targeting ubiquitination machinery in cystic fibrosis: Where do we stand?

Targeting ubiquitination machinery in cystic fibrosis: Where do we stand?

Journal: Cellular and molecular life sciences : CMLS

Published: March 27, 2024

SUMOylation Inhibition Enhances Protein Transcription under CMV Promoter: A Lesson from a Study with the F508del-CFTR Mutant.

SUMOylation Inhibition Enhances Protein Transcription under CMV Promoter: A Lesson from a Study with the F508del-CFTR Mutant.

Journal: International journal of molecular sciences

Published: December 13, 2023

Analysis of the phosphoproteome of CK2α(-/-)/Δα' C2C12 myoblasts compared to the wild-type cells.

Analysis of the phosphoproteome of CK2α(-/-)/Δα' C2C12 myoblasts compared to the wild-type cells.

Journal: Open biology

Published: February 22, 2023

KDM2A and KDM3B as Potential Targets for the Rescue of F508del-CFTR.

KDM2A and KDM3B as Potential Targets for the Rescue of F508del-CFTR.

Journal: International journal of molecular sciences

Published: July 28, 2022

Mechanism of CK2 Inhibition by a Ruthenium-Based Polyoxometalate.

Mechanism of CK2 Inhibition by a Ruthenium-Based Polyoxometalate.

Journal: Frontiers in molecular biosciences

Published: March 28, 2022

Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants.

Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants.

Journal: Cellular and molecular life sciences : CMLS

Published: January 26, 2022

Targeting CK2 in cancer: a valuable strategy or a waste of time?

Targeting CK2 in cancer: a valuable strategy or a waste of time?

Journal: Cell death discovery

Published: September 13, 2021

How can a traffic light properly work if it is always green? The paradox of CK2 signaling.

How can a traffic light properly work if it is always green? The paradox of CK2 signaling.

Journal: Critical reviews in biochemistry and molecular biology

Published: April 12, 2021

Protein kinase CK2 inhibition as a pharmacological strategy.

Protein kinase CK2 inhibition as a pharmacological strategy.

Journal: Advances in protein chemistry and structural biology

Published: February 26, 2021

A mutational approach to dissect the functional role of the putative CFTR "PTM-CODE".

A mutational approach to dissect the functional role of the putative CFTR "PTM-CODE".

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: December 23, 2020

Showing 1-12 of 36

Last Updated: 09/26/2026